ClinicalTrials.Veeva

Menu

New Modality for Post Covid Syndrome Patients

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Post Covid Syndrome

Treatments

Device: laser acupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT05271500
P.T.REC/012/003582

Details and patient eligibility

About

Coronavirus (19) is a pandemic that affects many countries allover the world. Many patients experienced symptoms as dyspnea and fatigue after their recovery from coronavirus . These symptoms appear to occur regardless the severity of the infection. In addition, many studies reported change in the inflammatory status and immunity in post covid patients. laser acupuncture is a painless noninvasive modality that is used in treating many diseases. laser acupuncture appear to have a role in relieving symptoms, altering inflammatory status and boosting immunity in post covid patients.

Enrollment

80 estimated patients

Sex

All

Ages

30 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age will be ranged from 30 to 40 years
  • patients were diagnosed as covid 19 by polymerase chain reaction test using nasopharyngeal swap
  • patients will be negative polymerase chain reaction test (pcr) with symptoms of dyspnea and fatigue.
  • patients will be recruited after 2 weeks post the negative pcr
  • patients who want to participate and complete the study till the end

Exclusion criteria

  • patients with photosensitivity
  • pacemaker plantation pregnant women
  • BMI more than 30kg/m2 infection or inflammation at the site of acupuncture laser malignancy uncontrolled diabetes psychiatric disorders or mental retardation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups, including a placebo group

group(1)
Active Comparator group
Description:
40 post covid 19 patients will receive laser acupuncture
Treatment:
Device: laser acupuncture
group(2)
Placebo Comparator group
Description:
40 post covid patients will receive placebo laser acupuncture in which laser will be off
Treatment:
Device: laser acupuncture

Trial contacts and locations

0

Loading...

Central trial contact

salma alghitany, PHD degree; sandra girguis, PHD degree

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems